GEMoaB Monoclonals GmbH
General information
GEMoaB Monoclonals GmbH
Tatzberg 47
01307 Dresden, Saxony
Germany
Contact person: Michael Pehl, CEO
Company main phone: +49 (351) 44664500
Website: www.gemoab.com
Tatzberg 47
01307 Dresden, Saxony
Germany
Contact person: Michael Pehl, CEO
Company main phone: +49 (351) 44664500
Website: www.gemoab.com
| Year founded: | 2011 |
| Source of foundation: | Independent foundation |
Corporate description / mission:
GEMoaB GmbH is a privately-owned, limited liability biopharmaceutical company based in Dresden, Germany. The company discovers, develops, manufactures, and commercializes next-generation immunotherapies for the treatment of cancer patients with a high unmet medical need.
GEMoaB GmbH is a privately-owned, limited liability biopharmaceutical company based in Dresden, Germany. The company discovers, develops, manufactures, and commercializes next-generation immunotherapies for the treatment of cancer patients with a high unmet medical need.
State of ownership: Private / independent
Headquarters: Yes
Headquarters: Yes
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
Summary Products / Services / Technologies
Description of products:
GEM333
GEM3PSCA
UniCAR-T-PSMA
UniCAR-T 3, etc.
GEM333
GEM3PSCA
UniCAR-T-PSMA
UniCAR-T 3, etc.
Technology used:
UniCAR/RevCAR Platforms
ATAC Platform
UniCAR/RevCAR Platforms
ATAC Platform
© 2022 Biotechgate by Venture Valuation